Clinical trial
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions
NCT07225751 is registered in ClinicalTrials.gov with Kuros Biosurgery AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions
- Lead sponsor
- Kuros Biosurgery AG
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 25, 2025
- Completion date
- December 31, 2028
- Enrollment
- 126 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
ankle arthrodesis or arthroplasty, ankle deformity, ankle disease, hindfoot arthrodesis, hindfoot fusion, hindfoot pathologies